📈 Live Market Tracking
AI-Powered NSE Corporate Announcements Analysis
Indraprastha Medical Approves Q3 Results; Appoints Harsh Pati Singhania to Board for 5-Year Term
Indraprastha Medical Corporation (Indraprastha Apollo) has approved its financial results for the quarter and nine months ended December 31, 2025. A significant update was provided regarding the ongoing land lease litigation for the Sarita Vihar hospital, with the Delhi Government filing a new affidavit in the Supreme Court. The company also announced major board changes, including the appointment of high-profile industrialist Harsh Pati Singhania as an Independent Director. Additionally, three existing independent directors were re-appointed for five-year terms, ensuring continuity in governance.
Key Highlights
Approved un-audited financial results for the quarter and nine-month period ended December 31, 2025.
Noted a new affidavit filed by the Delhi Government in the Supreme Court regarding the Sarita Vihar hospital land lease matter.
Appointed Mr. Harsh Pati Singhania (CMD of JK Paper) as an Independent Director for a 5-year term until February 2031.
Re-appointed three Independent Directors (Salil Singhal, Vineeta Rai, and Madhumita Ganguli) for second 5-year terms.
The board meeting concluded on February 3, 2026, after a session lasting over two hours.
💼 Action for Investors
Investors should closely monitor the Supreme Court proceedings regarding the land lease, as this remains a critical legal overhang for the company's primary asset. The addition of experienced industrial leadership to the board is a positive development for corporate governance.
Indraprastha Medical Appoints Harsh Pati Singhania to Board; Updates on Land Lease Legal Case
Indraprastha Medical Corporation (Indraprastha Apollo Hospitals) has approved its Q3 FY26 financial results and announced significant board changes. Mr. Harsh Pati Singhania, CMD of JK Paper, has been appointed as an Independent Director for a five-year term effective February 3, 2026. The company also re-appointed three other Independent Directors, including Mr. Salil Singhal and Ms. Madhumita Ganguli, for second five-year terms. Additionally, the company is reviewing a new affidavit filed by the Delhi Government in the Supreme Court regarding the ongoing land lease and free patient treatment matter.
Key Highlights
Approved unaudited financial results for the quarter and nine months ended December 31, 2025
Appointed Mr. Harsh Pati Singhania as Independent Director for a 5-year term ending February 2031
Re-appointed three Independent Directors for 5-year terms to ensure board continuity
Noted a new affidavit from the Govt. of NCT of Delhi regarding the Sarita Vihar hospital land lease litigation
The ongoing 'Free Patient Matter' remains under consideration by the Hon'ble Supreme Court of India
💼 Action for Investors
Investors should closely monitor the Supreme Court proceedings regarding the land lease and free patient matter as it represents a significant operational risk. The addition of high-profile industrial leaders to the board is a positive signal for corporate governance.
Indraprastha Medical Appoints Harsh Pati Singhania to Board; Approves Q3 FY26 Results
Indraprastha Medical Corporation (Indraprastha Apollo) has approved its Q3 FY26 financial results and announced a significant board refresh. Mr. Harsh Pati Singhania, CMD of JK Paper, has been appointed as an Independent Director for a five-year term. Additionally, three existing independent directors, including Ms. Vineeta Rai and Mr. Salil Singhal, were re-appointed for second five-year terms. The company also disclosed a legal update regarding an affidavit filed by the Delhi Government in the ongoing Supreme Court case concerning the hospital's land lease and free patient treatment obligations.
Key Highlights
Appointment of Mr. Harsh Pati Singhania as Non-Executive Independent Director for a 5-year term (2026-2031).
Re-appointment of Ms. Vineeta Rai and Mr. Salil Singhal for second 5-year terms effective February 8, 2026.
Approval of un-audited financial results for the quarter and nine months ended December 31, 2025.
Ongoing legal monitoring of the Supreme Court case (SLP 29482/2009) regarding the hospital's land lease in Sarita Vihar.
💼 Action for Investors
The addition of high-profile industrial leadership to the board is a positive for governance, but investors should primarily focus on the upcoming Q3 earnings details and the eventual Supreme Court ruling on the land lease matter.
Indraprastha Medical Approves Q3 Results, Appoints Harsh Pati Singhania as Independent Director
Indraprastha Medical Corporation Limited (Indraprastha Apollo) has approved its Q3 FY26 financial results and announced several key board appointments. Mr. Harsh Pati Singhania, CMD of JK Paper, joins as an Independent Director, while three others, including Mr. Salil Singhal, have been re-appointed for five-year terms. The company is also monitoring a legal update involving an affidavit filed by the Delhi Government in the Supreme Court regarding land lease and free patient treatment. These developments highlight a focus on governance and ongoing regulatory challenges.
Key Highlights
Approved un-audited financial results for the quarter and nine months ended December 31, 2025
Appointed Mr. Harsh Pati Singhania (CMD, JK Paper) as Independent Director for a 5-year term starting Feb 2026
Re-appointed three Independent Directors, including Mr. Salil Singhal, for 5-year terms
Noted a new affidavit filed by the Delhi Government in the Supreme Court regarding the 'Free Patient Matter' and land lease
💼 Action for Investors
Investors should review the detailed Q3 financial performance once published and closely monitor the Supreme Court proceedings regarding the land lease, as it represents a significant regulatory risk.
Indraprastha Medical Appoints Harsh Pati Singhania as Director; Re-appoints 3 Independent Directors
Indraprastha Medical Corporation has appointed Mr. Harsh Pati Singhania, CMD of JK Paper, as an Independent Director for a five-year term starting February 3, 2026. The board also approved the re-appointment of three other Independent Directors—Mr. Salil Singhal, Ms. Vineeta Rai, and Ms. Madhumita Ganguli—for subsequent five-year terms. Additionally, the company noted a new affidavit filed by the Delhi Government regarding a long-standing legal matter (SLP 29482/2009) concerning free patient care and the hospital's land lease. While Q3 FY26 financial results were approved, specific figures were not disclosed in this announcement.
Key Highlights
Appointment of Mr. Harsh Pati Singhania (CMD, JK Paper) as Independent Director for a 5-year term until Feb 2031.
Re-appointment of three Independent Directors for 5-year terms to ensure board continuity and governance.
Update on pending Supreme Court matter regarding land lease and free patient care obligations with the Delhi Government.
Approval of un-audited financial results for the quarter and nine months ended December 31, 2025.
💼 Action for Investors
Investors should monitor the Supreme Court's decision on the land lease and free patient care matter as it remains a key regulatory risk. The induction of high-profile industry leaders to the board is a positive sign for long-term strategic oversight.
Indraprastha Medical Approves Q3 Results; Appoints Harsh Pati Singhania to Board
Indraprastha Medical Corporation (Indraprastha Apollo Hospitals) approved its Q3 FY26 financial results and addressed a critical legal update regarding its land lease. The company noted a new affidavit filed by the Delhi Government in the Supreme Court concerning the 'Free Patient Matter' and land lease terms. On the governance front, the board appointed Mr. Harsh Pati Singhania, CMD of JK Paper, as an Independent Director for five years. Additionally, three existing Independent Directors were re-appointed for second five-year terms, ensuring leadership continuity.
Key Highlights
Approved un-audited financial results for the quarter and nine months ended December 31, 2025.
Appointed Mr. Harsh Pati Singhania as an Independent Director for a 5-year term effective February 3, 2026.
Re-appointed three Independent Directors (Salil Singhal, Vineeta Rai, and Madhumita Ganguli) for 5-year terms.
Noted a new affidavit from the Delhi Government in the ongoing Supreme Court case (SLP 29482/2009) regarding the hospital's land lease.
💼 Action for Investors
Investors should closely monitor the Supreme Court's upcoming deliberations on the land lease and free patient matter, as this remains a significant regulatory overhang. The addition of high-profile industrial leadership to the board is a positive indicator for corporate governance.